<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-157108</identifier>
<setSpec>0034-7973</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Guideline for the interpretation of the results of serologic study front HBV and HCV in gametes donors</dc:title>
<dc:description xml:lang="en">The study of the transmission infectious diseases in gametes donors is regulated by BD 4l2/BB. Between the diseases of obligatory study are present hepatitis B and B with repetitions of the serological study each 6 months for semen donors. In this work we show a protocol of performance before the results of the serological study of hepatitis B and E and their interpretation depending on the transaminasas value and personal antecedents. The tests recommended to discard an infection by HBV are HBs antigen and anti-HBc antibodies and to discard infection by HCV are anti-HVC antibodies (AU)</dc:description>
<dc:creator>Clavero, A</dc:creator>
<dc:creator>Liébana, JM</dc:creator>
<dc:creator>Sánchez, E</dc:creator>
<dc:creator>Acal, JA</dc:creator>
<dc:creator>Bernal, MC</dc:creator>
<dc:creator>Gonzalvo, MC</dc:creator>
<dc:creator>Castilla, JA</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El estudio de enfermedades infecciosas de transmisión en donantes de gametos está regulado por el RD 412/96. Entre las enfermedades de estudio obligatorio se encuentran las hepatitis B y C con repeticiones del estudio serológico cada seis meses para los donantes de semen. En este trabajo presentamos un protocolo de actuación ante los resultados de los estudios serológicos de hepatitis B y C y su interpretación en función de los valores de transaminasas y antecedentes personales. Las pruebas serológicas recomendadas para descartar infección por VHB son antígeno HBs y anticuerpos anti-HBc y para descartar infección por VHC son los anticuerpos anti-VHC (AU)</dc:description>
<dc:source>Rev. diagn. biol;53(4): 192-194, oct.-dic. 2004. graf</dc:source>
<dc:identifier>ibc-157108</dc:identifier>
<dc:title xml:lang="es">Guía para la interpretación de los resultados del estudio serológico frente VHB y VHC en donantes de gametos</dc:title>
<dc:subject>^d19279^s22048</dc:subject>
<dc:subject>^d36295^s22074</dc:subject>
<dc:subject>^d19279^s22049</dc:subject>
<dc:subject>^d13043^s22063</dc:subject>
<dc:subject>^d36295^s22066</dc:subject>
<dc:subject>^d29636</dc:subject>
<dc:subject>^d13078^s22083</dc:subject>
<dc:subject>^d13043^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14408</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d19279^s22045</dc:subject>
<dc:subject>^d6664^s22012</dc:subject>
<dc:subject>^d6664^s22016</dc:subject>
<dc:subject>^d30351^s22012</dc:subject>
<dc:subject>^d13078^s22045</dc:subject>
<dc:subject>^d30351^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200412</dc:date>
</metadata>
</record>
</ibecs-document>
